Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 667 | 547 | 234 | 313 | 502 |
| Gross Profit | 667 | 547 | 234 | 313 | 502 |
| Operating Expenses | 1,714 | 1,681 | 3,023 | 1,455 | 2,113 |
| Operating Income | -1,047 | -1,134 | -2,789 | -1,142 | -1,611 |
| Interest Expense | 0 | 3 | 5 | 0 | 0 |
| Other Income | 1,130 | 570 | 1,744 | 333 | 27 |
| Pre-tax Income | 83 | -567 | -1,050 | -809 | -1,584 |
| Net Income Continuous | 114 | -567 | -1,050 | -809 | -1,541 |
| Net Income Discontinuous | 138 | -42 | -40 | 75 | 658 |
| Net Income | $252 | $-609 | $-1,090 | $-734 | $-883 |
| EPS Basic Total Ops | 0.01 | -0.05 | -0.09 | -0.06 | -0.06 |
| EPS Basic Continuous Ops | 0.01 | -0.05 | -0.09 | -0.07 | -0.13 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 |
| EPS Diluted Total Ops | 0.01 | -0.05 | -0.09 | -0.06 | -0.06 |
| EPS Diluted Continuous Ops | 0.01 | -0.05 | -0.09 | -0.07 | -0.13 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.05 | -0.09 | N/A | N/A |
| EBITDA(a) | $-176 | $-1,038 | $-2,609 | $-1,009 | $-974 |